Search
for
Sort by
Research 301–330 of 1000+
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Androgen Replacement in Women: A Commentary
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Perspectives of Kennedy's disease
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- What is the Rationale for Androgen Therapy for Women?
- Therapeutic options in the polycystic ovary syndrome
- Lichen Planopilaris in the Androgenetic Alopecia Area: A Pitfall for Hair Transplantation
- Hirsutism and virilisation.
- Post-Finasteride Adverse Effects in Male Androgenic Alopecia: A Case Report of Vitiligo
- Solitary fixed drug eruption caused by finasteride
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Polycystic ovary syndrome: Challenges in adolescence
- Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
- Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Aching alopecia
- Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
- Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia
- Characteristics of phenotypes (clinical variants) of polycystic ovary syndrome in women of reproductive age
- Factors associated with risk for depression among women with polycystic ovarian syndrome
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- Relationship between the exercise and severity of androgenic alopecia.
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Synthesis and Study of Some 17a-aza-D-homo Steroids as 5α-Reductase Inhibitors
- It is not invisible! A case report of 2 patients with scalp Lichen Planopilaris mimicking Androgenic Alopecia
- Clinical and Hormonal Evaluation of Androgen Excess